Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT05464160
Eligibility Criteria:
Inclusion Criteria:
* Age between 18-75 years
* Picture of subacute sABI (20 days to 6 months after the acute event), of any etiology (traumatic, vascular, metabolic)
* Presence of spasticity in the affected limb as assessed by the Modified Ashwort Scale (MAS) ≥ 1+
Exclusion Criteria:
* recent treatment with botulinum toxin (within 3 months);
* ongoing treatment with systemic muscle relaxant drugs (baclofen, tizanidine, benzodiazepines);
* deep vein thrombosis;
* central/peripheral accesses ipsilateral to the limb(s) to be treated;
* oncological diseases;
* epilepsy;
* open skin lesions or local infections.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05464160
Study Brief:
Protocol Section:
NCT05464160